A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

The overall number of respiratory virus cases in hospital emergency departments dropped for the second consecutive week — a ...

RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

The Ministry of Public Health yesterday confirmed the discovery of a new coronavirus, HKU5-CoV-2, by a laboratory in China but said no human infections have been recorded as yet.Dr Opas Karnkawinpong, ...

The Ministry of Public Health has verified the identification of a new coronavirus, HKU5-CoV-2, by a laboratory in China, stating that no human infections have been reported to date.

An unvaccinated child died of measles in West Texas, officials said Wednesday, marking the first death in an ongoing outbreak ...

January was a brutal month. I started our new year with a viral infection that lingered for weeks. A trip to the doctor’s ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...

Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health ...

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody ...